Mutations in high-risk breast cancer genes or genes associated with syndromic diagnoses (CDH1, PALB2, PTEN, STK11, and TP536, 20, 21) were identified in 1.4% of the FBC cohort (Table 2). This evidence concerns the gene CDH1 and breast carcinoma.